Cervical mucus antibodies against human papillomavirus type 16, 18, and 33 capsids in relation to presence of viral DNA

Journal of Clinical Microbiology

Volumn 34, Issue 12, 1996, Pages 3056-3062

  Wang, Zhaohui ^a   Hansson, Bengt Göran ^b   Forslund, Ola ^b   Dillner, Lena ^a   Sapp, Martin ^c   Schiller, John T ^d   Bjerre, Bengt ^b   Dillner, Joakim ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

^d NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN A; VIRUS ANTIBODY; VIRUS DNA;

ANTIBODY RESPONSE; ARTICLE; COLPOSCOPY; DNA DETERMINATION; ENZYME LINKED IMMUNOSORBENT ASSAY; PAPILLOMA VIRUS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; UTERINE CERVIX MUCUS; VIRUS CAPSID; VIRUS CHARACTERIZATION;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPE 16; MIRIDAE; PAPILLOMAVIRUS;

EID: 0029923959     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.34.12.3056-3062.1996     Document Type: Article

References (24)

1. Andersson-Ellström, A., J. Dillner, B. Hagmar, J. Schiller, M. Sapp, L. Forssman, and I. Milsom. 1996. Comparison of development of serum antibodies to HPV16 and HPV33 and acquisition of cervical HPV DNA among sexually experienced and virginal young girls. A longitudinal cohort study. Sex. Transm. Dis. 23:234-238.
2. Bistoletti, P., A. Zellbi, J. Moreno-Lopez, and A. Hjerpe. 1988. Genital papillomavirus infection after treatment for cervical intraepithelial neoplasia (CIN) III. Cancer 62:2056-2059.
3. Breitburd, F., R. Kirnbauer, N. L. Hubbert, J. T. Schiller, and G. Orth. 1995. Immunization with virus-like particles from cottontail rabbit papillomavirus (CRPV) can protect against experimental CRPV infection. J. Virol. 69: 3959-3963.
4. Cheng, G., J. P. Icenogle, R. Kirnbauer, N. L. Hubbert, M. E. St. Louis, C. L. Han, E. I. Svare, S. K. Kjaer, D. R. Lowy, and J. T. Schiller. 1995. Divergent human papillomavirus type 16 variants are serologically cross-reactive. J. Infect. Dis. 172:1584-1587.
5. Christensen, N. D., J. W. Kreider, K. V. Shah, and R. F. Rando. 1992. Detection of human serum antibodies that neutralize infectious human papillomavirus type 11 virions. J. Gen. Virol. 73:1261-1267.
6. Chua, K. L., F. Wiklund, P. Lenner, T. Ångström, G. Hallmans, F. Bergman, M. Sapp, J. Schiller, G. Wadell, A. Hjerpe, and J. Dillner. A prospective cohort study on the risk to develop cervical intraepithelial neoplasia among healthy subjects with serum antibodies to HPV, in comparison with presence of HPV DNA in Papanicolaou smears. Int. J. Cancer, in press.
7. Dillner, J. 1995. Serology of human papillomavirus. Cancer J. 8:264-269.
8. Dillner, L., Z. Bekassy, N. Jonsson, J. Moreno-Lopez, and J. Blomberg. 1989. Detection of IgA antibodies against human papillomavirus in cervical secretions from patients with cervical intraepithelial neoplasia. Int. J. Cancer 43:36-40.
9. Dillner, L., A. Fredriksson, E. Persson, O. Forslund, B. G. Hansson, and J. Dillner. 1993. Antibodies against papillomavirus antigens in cervical secretions from condyloma patients. J. Clin. Microbiol. 31:192-197.
10. Dillner, J., I. Kallings, C. Brihmer, B. Sikström, P. Lehtinen, M. Lehtinen, J. T. Schiller, M. Sapp, and P. A. Mårdh. 1996. Seropositivity to human papillomavirus type 16, 18 or 33 capsids and to Chlamydia trachomatis are markers of sexual behaviour. J. Infect. Dis. 173:1394-1398.
11. Elfgren, K., P. Bistoletti, L. Dillner, J. M. M. Walboomers, C. J. L. M. Meijer, and J. Dillner. 1996. Conization of CIN is followed by a disappearance of HPV DNA and a decline of serum and cervical mucus antibodies against HPV antigens. Am. J. Obstet. Gynecol. 174:937-942.
12. Forslund, O., B. G. Hansson, P. Rymark, and B. Bierre. 1993. Human papillomavirus DNA in urine samples with that in simultaneously collected urethra and cervix samples. J. Clin. Microbiol. 31:1975-1979.
13. Guerrero, E., R. W. Daniel, F. X. Bosch, X. Castellsague, N. Munoz, L. Gonzalez, L. Tafur, I. Izarzugaza, and K. V. Shah. 1992. Comparison of ViraPap, Southern hybridization, and polymerase chain reaction methods for human papillomavirus identification in an epidemiological investigation of cervical cancer. J. Clin. Microbiol. 30:2951-2959.
14. Hansson, B. G., O. Forslund, B. Bjerre, K. Lindholm, and E. Nordenfelt. 1993. Human papillomavirus types in routine cytological screening and at colposcopic examination. Eur. J. Obstet. Gynecol. Reprod. Biol. 52:49-55.
15. Heino, P., C. Eklund, V. Fredriksson-Shahnazarian, S. Goldman, J. T. Schiller, and J. Dillner. 1995. Association of serum IgG antibodies against human papillomavirus type 16 capsids with anal epidermoid carcinoma. J. Natl. Cancer Inst. 87:437-440.
16. Kirnbauer, R., N. L. Hubbert, C. M. Wheeler, T. M. Becker, D. R. Lowy, and J. T. Schiller. 1994. A virus-like particle KLISA detects serum antibodies in a majority of women infected with human papillomavirus type 16. J. Natl. Cancer Inst. 86:494-498.
17. Lorincz, A. T., R. Reid, A. B. Jenson, M. D. Greenberg, VV. D. Lancaster, and R. J. Kurman. 1992. Human papillomavirus infection of the cervix: relative risk associations of 15 common anogenital types. Obstet. Gynecol. 79:328-337.
18. Manos, M. M., and Y. Ting. 1989. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
19. Mehta, C. P., N. R. Patel, and R. Gray. 1985. Computing exact confidence intervals for the common odds ratio in several 2x2 contingency tables. J. Am. Stat. Assoc. 80:969-973.
20. Rymark, P., O. Forslund, B. G. Hansson, and K. Lindholm. 1993. Genital HPV infection: not a local but a regional infection. Genitourinary Med. 69:18-22.
21. Walboomers, J. M. M., P. W. J. Melkert, A. J. C. Van den Brule, P. J. F. Snijders, and C. J. L. M. Meyer. 1992. The polymerase chain reaction for human papillomavirus screening in diagnostic cytopathology of the cervix, p. 153-172. In C. Herrington and J. McGee (ed.), Diagnostic molecular pathology: a practical approach, vol. 2. Oxford University Press, Oxford.
22. Wideroff, L., M. H. Schiffman, B. Nonenmacher, N. K. R. Hubbert, C. E. Greer, D. Lowy, A. T. Lorincz, M. M. Manos, A. G. Glass, D. R. Scott, M. E. Sherman, R. T. Kurman, J. Buckland, R. E. Tarone, and J. Schiller. 1995. Evaluation of seroreactivity to HPV16 virus-like particles in an incident case-control study of cervical neoplasia. J. Infect. Dis. 172:1425-1430.
23. Wikström, A., G. J. J. Van Dooroum, W. G. V. Quint, J. T. Schiller, and J. Dillner. 1995. Identification of human papillomavirus seroconversions. J. Gen. Virol. 76:529-539.
24. zur Hausen, H. 1991. Viruses in human cancers. Science 254:1167-1173.